EU approves Novartis's cell-based flu vaccine

Influenza Vaccines
Pandemic Influenza

Jun 13, 2007 (CIDRAP News) – The European Union (EU) has approved Novartis's seasonal influenza vaccine, Optaflu, putting the Swiss company in a position to become the first to market a flu vaccine grown in cell culture rather than eggs.

The vaccine has been approved for use in all 27 EU member states plus Iceland and Norway, Novartis announced today. It is expected to be available in Germany and Austria for the upcoming flu season and in the rest of the EU in 2008-09.

EU approval was expected after the European Medicines Agency's Committee for Medicinal Products for Human Use endorsed the vaccine on Apr 26.

"Optaflu marks the first major innovation in influenza vaccine manufacturing in over 50 years," Dr. Jorg Reinhardt, CEO of Novartis Vaccines and Diagnostics, said in a news release.

"The use of a Novartis proprietary cell culture technology enables a faster and more flexible start-up of vaccine manufacturing, offering the potential to more quickly respond to a potential pandemic influenza threat," the company announcement said.

Flu vaccines have been produced in chicken eggs since the 1950s. Growing the viruses in cell cultures is seen as much more flexible and somewhat faster than egg-based production, which takes several months. Several companies are developing cell-based production methods.

In 2001 European regulators approved a cell-based vaccine made by Solvay Pharmaceuticals for sale in the Netherlands, but the company has not marketed it. Solvay's Web site says that market introduction of the vaccine is expected in the near future.

Novartis said it expects to apply next year for US approval of Optaflu. In May 2006 the US government awarded Novartis a $220 million contract to develop cell-based flu vaccines, and in July 2006 the company announced plans for a $600 million plant in North Carolina to produce them.

See also:

Jun 13 Novartis news release
http://cws.huginonline.com/N/134323/PR/200706/1132639_5_2.html

Apr 27 CIDRAP News story "Panel supports EU approval of cell-based flu vaccine"

Jun 27, 2005, CIDRAP News story "Momentum builds for cell-culture flu vaccines"

This week's top reads

  1. Study: COVID can trigger changes to the immune system that may underlie persistent symptoms

    Over 90% of COVID-19 survivors had no neutralizing antibody activity at 10 months, implying that they had lost protection from reinfection.

    Mary Van Beusekom
    SARS-CoV-2

  2. Risk of long COVID has ebbed during pandemic, mostly thanks to vaccines, new data reveal

    The highest risk of developing long COVID was seen among patients infected with the original strain of the virus, when no vaccines were available. 

    Stephanie Soucheray
    long COVID

  3. Avian flu infects two more Colorado poultry cullers, one at second farm

    Early results from blood sampling found no evidence of earlier undetected infection in Michigan dairy farm workers exposed to sick cows.

    Lisa Schnirring
    layer farm birds

  4. H5N1 strikes another large layer farm in Colorado, dairy herd in Minnesota

    Colorado's latest layer farm outbreak occurred not far from where culling workers were infected in a similar event.

    Lisa Schnirring

  5. US COVID-19 activity continues to rise steadily

    Two wastewater systems show high levels across most of the country.

    Lisa Schnirring

  6. Multistate Listeria outbreak tied to meats sliced at delis sickens 28, kills 2

    Sixteen of 18 people sickened (89%) reported eating meats sliced at deli counters (not packaged meats). 

    Mary Van Beusekom

  7. India reports fatal Nipah virus infection

    State officials said the boy had eaten plum fruit from the neighborhood before his symptoms began.

    Lisa Schnirring

  8. Study suggests earlier US-licensed H5N1 vaccines prompt antibodies to current strain

    Scientists said until the newer more closely matched vaccine is approved, earlier licensed vaccines might be a useful bridge, if needed.

    Lisa Schnirring
    vials and syringe

  9. Colorado orders weekly bulk tank avian flu testing for dairy farms

    The state has now reported 49 outbreaks in dairy cows, nearly half of its licensed dairy farms.

    Lisa Schnirring
    bulk milk tank

  10. Shortage of BD blood culture tubes forcing some hospitals to make tough decisions

    A BD exec said supplier manufacturing problems are behind the disruption and that more supplies should become available in September.

    Mary Van Beusekom
    Blood draw